At present, differential expression analysis of BMPs/BMPRs in a large sample is lacking, and the prognostic value of BMPs/BMPRs is far from sufficient in lung cancer, especially for lung adenocarcinoma. This evidence concerns the gene CLN5 and lung adenocarcinoma.